NorthWest Biotherapeutics Inc (NWBO)

[ilovetech]

Chiugray - Collecting multiple licensed revenue streams from multiple partners at higher volumes would effectively create that valuation. I actually disagree with the premise, that taking on the entire cost of the infrastructure required to keep 100% of all the product sales as a standalone would result in a higher valuation. The latter would actually result in a lower valuation. Keep in mind that NWBO is paving way for an unconventional business model that you'd have to consider when referencing what the ideal case would need to be to secure the so-called highest valuation.